Overview

Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn the pharmacokinetics of Ipilimumab when combined with Paclitaxel/Carboplatin or Dacarbazine
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Collaborator:
Medarex
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Dacarbazine
Ipilimumab
Paclitaxel